ME1 Insider Trading

Insider Ownership Percentage: 10.03%
Insider Buying (Last 12 Months): A$0.00
Insider Selling (Last 12 Months): A$0.00

Melodiol Global Health Insider Trading History Chart

This chart shows the insider buying and selling history at Melodiol Global Health by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Melodiol Global Health Share Price & Price History

Current Price: A$0.00
Price Change: +0.30 (1.20%)
As of 07/10/2023 05:03 PM ET

This chart shows the closing price history over time for ME1 up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table

Melodiol Global Health Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
1/17/2024Bruce LintonInsiderExpiry10,000,000A$0.00A$10,000.00
11/17/2023Jodi ScottInsiderIssued44,972,436A$0.01A$269,834.62
11/2/2023William LayInsiderExercise5,000,000A$0.00A$15,000.00
10/19/2023William LayInsiderExpiry5,000,000A$0.01A$35,000.00
6/30/2023William LayInsiderIssued10,000,000A$0.01A$70,000.00
See Full Table

SEC Filings (Institutional Ownership Changes) for Melodiol Global Health (ASX:ME1)

Melodiol Global Health Limited develops, registers, and commercializes pharmaceutical-grade cannabis, and hemp-based nutraceutical products and treatments for human and other health in Europe, Canada, the Asia Pacific, the United States, and internationally. The company develops and commercializes therapeutic products; develops and sells beauty and personal care products under the Green Goo, Southern Butter, and Goodgoo brands; and cultivates, processes, and sells cannabis products. Its products include cannaQIX, a nutraceutical product containing hemp oil extract, and vitamins and minerals in a lozenge delivery system; the ImpACTIVE Pro Releaf Stick to provide relief to muscle aches, particularly in professional sport, and acts as an alternative to pharmacological solutions sold through online channels; Ritual Green, a dried flower; Ritual Sticks for pre-rolled joints; and Ritual Gold, a handheld vapouriser. In addition, the company develops Halucenex, which is in phase II clinical trials, which will test the efficacy of psilocybin on treatment of resistant Post Traumatic Stress Disorder. Further, it engages in marketing of its hemp based food, feed supplements, and topical products; manufacture and sale of packaged consumer products; conducts clinical trial and development of synthetic psilocybin micro and macro dose formulations to treat treatment resistant depression and anxiety; and development of psychedelic medicines. The company was formerly known as Creso Pharma Limited and changed its name to Melodiol Global Health Limited in June 2023. Melodiol Global Health Limited was incorporated in 2015 and is headquartered in Nedlands, Australia.
Read More on Melodiol Global Health

Today's Range

Now: N/A

50 Day Range

MA: N/A

52 Week Range

Now: N/A

Volume

N/A

Average Volume

N/A

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.62

Who are the company insiders with the largest holdings of Melodiol Global Health?

Melodiol Global Health's top insider shareholders include:
  1. Bruce Linton (Insider)
  2. Jodi Scott (Insider)
  3. William Lay (Insider)
Learn More about top insider investors at Melodiol Global Health.